GSE216988 GSE216989 decitabine 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE216988_GSE216989_decitabine_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE216988_GSE216989_decitabine_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE216988_GSE216989_decitabine_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE216988_GSE216989_decitabine_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

Rho GTPase activating protein 23

Gene

G protein signaling modulator 3

Gene

cytoskeleton regulator RNA

Gene

urothelial cancer associated 1

Gene

LOXL1 antisense RNA 1

Gene

long intergenic non-protein coding RNA 649

Gene

tripartite motif containing 31

Gene

small nucleolar RNA host gene 18

Gene

uncharacterized LOC339260

Gene

NF-kappaB interacting lncRNA

  • Gene

    Rho GTPase activating protein 23


  • Gene

    G protein signaling modulator 3


  • Gene

    cytoskeleton regulator RNA


  • Gene

    urothelial cancer associated 1


  • Gene

    LOXL1 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 649


  • Gene

    tripartite motif containing 31


  • Gene

    small nucleolar RNA host gene 18


  • Gene

    uncharacterized LOC339260


  • Gene

    NF-kappaB interacting lncRNA

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.